Beighton cut-offs for generalized joint hypermobility 5 This commentary refers to Beighton scores and cutoffs across the lifespan: cross-sectional study of an Australian population, Harjodh Singh et al.
and whether or not GJH is a risk factor for injury. However, there is a growing evidence base for an association between GJH and musculoskeletal pain, fatigue and disability [1] . Furthermore, readers will be aware that joint laxity is also a feature of several of the hereditary 20 disorders of connective tissue, such as EhlersDanlos Syndromes, Marfan Syndrome and Osteogenesis Imperfecta. The Beighton scale forms part of the diagnostic criteria for some of these syndromes. Therefore, an accurate method for identifying joint hypermobility 25 across the lifespan, in different ethnic groups and in both males and females, is required in order to make an accurate diagnosis. The population study published in this issue
AQ2
of Rheumatology entitled 'Beighton scores and cutoffs across the lifespan: cross-sectional study of an 30 Australian population' [2] is timely, and provides readers with a well-reasoned argument for proposed genderspecific cut-offs across the lifespan. The authors of the current study critically justify the 55 case for using Beighton score cut-offs closest to the uppermost 5%, which correlates to 2 S.D. above the mean. This thinking is in line with the 1965 recommendation of the American Academy of Orthopaedic Surgeons seeking to prevent overdiagnosis of joint hypermobility 60 and to allow for the greatest accuracy in determining variations from the normal range of movement across agegroups and genders. Using this new criterion, a portrait of GJH in a typical Australian population is presented. The paper concludes with an interesting recommendation by the authors of using a second assessment of joint mobility, such as the Lower limb Assessment Scale, which examines multidimensional joint and tissue movement in order to improve the validity of a diagnosis. This would be aimed at children, as that measure has not yet been vali-70 dated in adults. In conclusion, this is an important article that provides researchers and clinicians with a new approach to assessing and determining GJH across the lifespan.
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